CTOs on the Move

Bioatla

www.bioatla.com

 
BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.bioatla.com
  • 11011 Torreyana Road
    San Diego, CA USA 92121
  • Phone: 858.558.0708
  • Fax: 858.558.0701

Executives

Name Title Contact Details

Funding

Bioatla raised $30M on 06/11/2015
Bioatla raised $72.5M on 07/15/2020

Similar Companies

Amkai

Amkai is a Armonk, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

JTECH Medical

JTECH Medical is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Relievant Medsystems

Relievant Medsystems, Inc., a privately held medical device company pioneering the INTRACEPT therapy of nerve ablation within vertebral bodies for the treatment of chronic low back pain (CLBP). The INTRACEPT Intraosseous Nerve Ablation System is a patent-protected, minimally invasive, implant-free therapy that utilizes radiofrequency energy delivered into the vertebral body of the spine to ablate the Basivertebral Nerve (BVN). This nerve, characterized in peer-reviewed literature reporting studies of pain signal transmission and in preclinical and clinical evaluations, is a significant contributor in the transduction of pain arising from degeneration of the vertebral bodies associated with CLBP. The INTRACEPT Intraosseous Nerve Ablation System leverages proprietary instruments and methods to disable this nerve.

Gateway EDI Inc

Gateway EDI Inc is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.